Researchers have explored DSIP for possible effects on sleep regulation, stress response, pain signaling, endocrine function, and nervous system activity
This not only saves excipient costs but also simplifies formulations and reduces the difficulty of quality control
But although there may be tantalizing clues for helping patients with unwanted impulses, GLP-1 and GIP inhibitors may not be optimally designed to treat them sufficiently and need further research, according to a case study from the Perelman School of Medicine, published in Nature Medicine
Even if pigmentation occurs, the long-term risks outweigh any short-term cosmetic benefit
For someone just starting at 0.25mg weekly, that margin matters
The rising prevalence of obesity, diabetes, and other metabolic disorders is increasing regional demand for innovative GLP-1 receptor agonist therapies